(MENAFN- EIN Presswire) EINPresswire/ -- Creative Biolabs has expanded its portfolio of primary cell systems and functional assay tools, expanding its selection of primary macrophage preparations, ...
Complement‑targeted therapeutics continue to expand, with C3, C5, and alternative‑pathway inhibitors advancing through clinical pipelines. Creative Biolabs’ complement assay kit suite spans the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する